PT1558935E - Composições de libertação controlada - Google Patents

Composições de libertação controlada Download PDF

Info

Publication number: PT1558935E
Authority: PT; Portugal
Prior art keywords: controlled; release; matrix; agent; release compositions
Prior art date: 2002-10-25

Application number

PT03809236T

Other languages

English (en)

Inventor

Vincent Lenaerts

Sonia Gervais

Miloud Rahmouni

Damon Smith

Patricia Laure Ouadji-Njiki

Jonathan Bacon

Rachid Ouzerourou

Original Assignee

Labopharm Inc

Labopharm Europe Ltd

Labopharm Barbados Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-25

Filing date

2003-10-27

Publication date

2008-10-16

2003-10-27 Application filed by Labopharm Inc, Labopharm Europe Ltd, Labopharm Barbados Ltd filed Critical Labopharm Inc

2008-10-16 Publication of PT1558935E publication Critical patent/PT1558935E/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT03809236T 2002-10-25 2003-10-27 Composições de libertação controlada PT1558935E (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US28102602A	2002-10-25	2002-10-25
US50906202P	2002-10-25	2002-10-25
PCT/CA2003/001637 WO2004038428A2 (en)	2002-10-25	2003-10-27	Controlled-release compositions

Publications (1)

Publication Number	Publication Date
PT1558935E true PT1558935E (pt)	2008-10-16

Family

ID=34976756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT03809236T PT1558935E (pt)	2002-10-25	2003-10-27	Composições de libertação controlada

Country Status (19)

Country	Link
EP (1)	EP1558935B1 (pt)
JP (1)	JP2006507276A (pt)
KR (1)	KR101120729B1 (pt)
AT (1)	ATE400819T1 (pt)
AU (1)	AU2003275854B9 (pt)
BR (1)	BR0315657A (pt)
CA (1)	CA2503361C (pt)
DE (1)	DE60322091D1 (pt)
DK (1)	DK1558935T3 (pt)
EC (1)	ECSP055748A (pt)
ES (1)	ES2310686T3 (pt)
HK (1)	HK1086475A1 (pt)
MX (1)	MXPA05004410A (pt)
NO (1)	NO20052515L (pt)
NZ (1)	NZ539869A (pt)
PT (1)	PT1558935E (pt)
RU (1)	RU2333745C2 (pt)
SI (1)	SI1558935T1 (pt)
WO (1)	WO2004038428A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8487002B2 (en)	2002-10-25	2013-07-16	Paladin Labs Inc.	Controlled-release compositions
TWI319713B (en)	2002-10-25	2010-01-21		Sustained-release tramadol formulations with 24-hour efficacy
US7201920B2 (en)	2003-11-26	2007-04-10	Acura Pharmaceuticals, Inc.	Methods and compositions for deterring abuse of opioid containing dosage forms
JP2005306778A (ja) *	2004-04-21	2005-11-04	Basf Ag	徐放性製剤及びその製造方法
CA2570916C (en)	2004-06-16	2013-06-11	Tap Pharmaceutical Products, Inc.	Pulsed release dosage form of a ppi
CA2491665A1 (fr) *	2004-12-24	2006-06-24	Louis Cartilier	Formulation de comprime pour liberation soutenue de principe actif
WO2007008752A2 (en)	2005-07-07	2007-01-18	Farnam Companies, Inc.	Sustained release pharmaceutical compositions for highly water soluble drugs
JP5269595B2 (ja) *	2005-09-09	2013-08-21	アンジェリーニラボファームリミテッドライアビリティカンパニー	１日１回投与用トラゾドン組成物
CN100437113C (zh) *	2006-04-11	2008-11-26	汪运山	一种检测血液中非那西丁与醋氨酚浓度比值的试剂盒
SI2010158T1 (sl)	2006-04-26	2016-08-31	Alphapharm Pty Ltd.	Nadzorovane formulacije sproščanja obsegajoče neoplaščeno(e) diskretno(e) enoto(e) in razširjena matrika sproščanja
AU2013202441B2 (en) *	2006-04-26	2016-02-25	Alphapharm Pty Ltd	Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
CN100387988C (zh) *	2006-07-25	2008-05-14	山东省医药工业研究所	一种布洛伪麻那敏复方制剂的含量检测方法
JP5467870B2 (ja)	2007-02-09	2014-04-09	アルファファームピーティーワイリミテッド	異なる物理的形態の２種以上の有効医薬成分を含有する投薬形態
EP2203166B1 (en) *	2007-10-16	2015-05-06	Paladin Labs Inc.	Bilayer composition for the sustained release of acetaminophen and tramadol
AU2009253739B2 (en)	2008-05-27	2014-02-06	Otolanum Ag	Methods of treating mammals with eustachian tube dysfunctions
US20120065221A1 (en)	2009-02-26	2012-03-15	Theraquest Biosciences, Inc.	Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
EP2488029B1 (en)	2009-09-30	2016-03-23	Acura Pharmaceuticals, Inc.	Methods and compositions for deterring abuse
EP2563349A4 (en) *	2010-04-23	2014-03-19	Paladin Labs Inc	NON-INTRAVENOUS-MODIFIED FORM COMPRISING A SOLID FORMULATION OF A BIOLOGICALLY ACTIVE LIQUID AGENT AND USES THEREOF
RU2451680C1 (ru)	2011-02-21	2012-05-27	Общество С Ограниченной Ответственностью "Научно-Исследовательская Компания "Медбиофарм"	Клатратный комплекс циклодекстрина или арабиногалактана с 9-фенил-симм-октагидроселеноксантеном, способ его получения (варианты), фармацевтическая композиция и лекарственное средство
AU2013352162B2 (en)	2012-11-30	2018-08-16	Acura Pharmaceuticals, Inc.	Self-regulated release of active pharmaceutical ingredient
WO2017040607A1 (en)	2015-08-31	2017-03-09	Acura Pharmaceuticals, Inc.	Methods and compositions for self-regulated release of active pharmaceutical ingredient
CN114177155B (zh) *	2020-09-08	2023-10-03	越洋医药开发(广州)有限公司	一种布洛芬控释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL119660A (en) *	1993-05-10	2002-09-12	Euro Celtique Sa	Controlled release formulation comprising tramadol
DE19530575A1 (de) *	1995-08-19	1997-02-20	Gruenenthal Gmbh	Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
CA2173818A1 (fr) *	1996-04-10	1997-10-11	Francois Chouinard	Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
EP1009387B1 (en) *	1997-07-02	2006-04-12	Euro-Celtique S.A.	Stabilized sustained release tramadol formulations
US6284273B1 (en) *	1998-02-24	2001-09-04	Vincent Lenaerts	Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
DE10014588A1 (de) *	2000-03-27	2001-10-04	Basf Ag	Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
DE10015479A1 (de) *	2000-03-29	2001-10-11	Basf Ag	Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität
US6607748B1 (en) *	2000-06-29	2003-08-19	Vincent Lenaerts	Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture
HU229291B1 (en) *	2001-01-31	2013-10-28	Evonik Roehm Gmbh	Multi-particulate form of medicament, comprising at least two differently coated forms of pellet

2003
- 2003-10-27 JP JP2004545654A patent/JP2006507276A/ja not_active Withdrawn
- 2003-10-27 AU AU2003275854A patent/AU2003275854B9/en not_active Expired
- 2003-10-27 ES ES03809236T patent/ES2310686T3/es not_active Expired - Lifetime
- 2003-10-27 RU RU2005115883/15A patent/RU2333745C2/ru not_active IP Right Cessation
- 2003-10-27 AT AT03809236T patent/ATE400819T1/de active
- 2003-10-27 CA CA2503361A patent/CA2503361C/en not_active Expired - Fee Related
- 2003-10-27 BR BR0315657-5A patent/BR0315657A/pt active IP Right Grant
- 2003-10-27 PT PT03809236T patent/PT1558935E/pt unknown
- 2003-10-27 DK DK03809236T patent/DK1558935T3/da active
- 2003-10-27 SI SI200331377T patent/SI1558935T1/sl unknown
- 2003-10-27 KR KR1020057007088A patent/KR101120729B1/ko active IP Right Grant
- 2003-10-27 NZ NZ539869A patent/NZ539869A/en not_active IP Right Cessation
- 2003-10-27 EP EP03809236A patent/EP1558935B1/en not_active Expired - Lifetime
- 2003-10-27 WO PCT/CA2003/001637 patent/WO2004038428A2/en active IP Right Grant
- 2003-10-27 MX MXPA05004410A patent/MXPA05004410A/es active IP Right Grant
- 2003-10-27 DE DE60322091T patent/DE60322091D1/de not_active Expired - Lifetime
2005
- 2005-04-25 EC EC2005005748A patent/ECSP055748A/es unknown
- 2005-05-25 NO NO20052515A patent/NO20052515L/no not_active Application Discontinuation
2006
- 2006-06-02 HK HK06106374A patent/HK1086475A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE400819T1 (de)	2008-07-15
NO20052515D0 (no)	2005-05-25
CA2503361A1 (en)	2004-05-06
RU2005115883A (ru)	2006-01-27
NZ539869A (en)	2007-09-28
ES2310686T3 (es)	2009-01-16
SI1558935T1 (sl)	2008-12-31
KR20050088281A (ko)	2005-09-05
HK1086475A1 (en)	2006-09-22
MXPA05004410A (es)	2005-11-23
KR101120729B1 (ko)	2012-04-23
AU2003275854A1 (en)	2004-05-13
NO20052515L (no)	2005-05-25
AU2003275854B2 (en)	2008-09-11
JP2006507276A (ja)	2006-03-02
DE60322091D1 (de)	2008-08-21
CA2503361C (en)	2012-02-28
RU2333745C2 (ru)	2008-09-20
EP1558935A2 (en)	2005-08-03
ECSP055748A (es)	2005-08-11
DK1558935T3 (da)	2008-11-17
BR0315657A (pt)	2005-09-13
WO2004038428A2 (en)	2004-05-06
EP1558935B1 (en)	2008-07-09
WO2004038428A3 (en)	2005-06-09
AU2003275854B9 (en)	2009-08-27

Publication	Publication Date	Title
HK1086475A1 (en)	2006-09-22	Controlled-release compositions
NL2000281A1 (nl)	2007-05-03	Vaste farmaceutische samenstellingen die pregabaline bevatten.
TWI235068B (en)	2005-07-01	Sustained-release pharmaceutical composition
JO2555B1 (en)	2010-09-05	Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
MX9707585A (es)	1997-12-31	Mezclas homogeneas de farmacos y aditivos de fusion a baja temperatura para liberacion controlada.
PL1631251T3 (pl)	2011-12-30	Tabletka o opóźnionym uwalnianiu i o określonej geometrii
GEP20064022B (en)	2007-01-10	Pharmaceutical formulations comprising oxycodone and naloxone
CA2457361A1 (en)	2003-02-20	Opioid agonist formulations with releasable and sequestered antagonist
CO4700474A1 (es)	1998-12-29	Formulacion oral de 2-metil-tieno-benzodiacepina
WO2005048979A3 (en)	2006-04-27	Pharmaceutical composition having casing with multiple micro tablets
TR200102880T2 (tr)	2002-03-21	Enjekte edilebilir naltrekson mikrokre bileçimleri ve bunlarìn eroin ve alkol tketiminin azaltìmì iin kullanìmì
ME00391B (me)	2011-10-10	Tableta bupropion hidrohlorida sa modifikovanim otpuštanjem
AU6517596A (en)	1997-02-05	Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors
HUP0000138A2 (hu)	2001-02-28	Szabályozott hatóanyag-leadású opioid analgetikumokat tartalmazó gyógyászati készítmények
BG105061A (en)	2001-07-31	Enteric coated pharmaceutical composition and method of manufacturing
HUP0301302A2 (en)	2003-08-28	Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and process for its manufacture
IE881195L (en)	1988-10-22	Ibuprofen sustained release matrix
CA2435729A1 (en)	2003-06-26	New film coating
WO2004064815A8 (en)	2004-09-30	Oral dosage formulation
SI2057984T1 (sl)	2010-04-30	Retardne tablete s hidromorfonom
GB2426097A (en)	2006-11-15	Codec Control
DE69512638D1 (de)	1999-11-11	Schnell auflösende orale darreichungsform
WO2004022002A3 (en)	2004-06-24	Combined immediate release and extended release analgesic composition
MY142195A (en)	2010-10-15	Controlled-release compositions
UA86929C2 (ru)	2009-06-10	Композиция с контролируемым высвобождением